Tubulis to Present First Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-Resistant Ovarian Cancer in Late-Breaking Oral Presentation at ESMO 2025

businesswire

Tubulis to Present First Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-Resistant Ovarian Cancer in Late-Breaking Oral Presentation at ESMO 2025 – NEWSnet – News… as it used to be

More Press Releases

Featured image for Auto-prepared featured image

June 18, 2026

Meme Coins News: Pepeto Presale Passes $10.28 Million as the Solana Price Prediction Targets $600 While SOL Tokens Collapse

June 18, 2026

Frankston Podiatry | Common Causes of Heel Pain and How to Treat Them

June 18, 2026

NYC Access Control Installation: Complete Step-by-Step Process Guide

June 18, 2026

Tubulis to Present First Phase I/IIa Trial Data for ADC Candidate TUB-040 in Platinum-Resistant Ovarian Cancer in Late-Breaking Oral Presentation at ESMO 2025

Meme Coins News: Pepeto Presale Passes $10.28 Million as the Solana Price Prediction Targets $600 While SOL Tokens Collapse

Frankston Podiatry | Common Causes of Heel Pain and How to Treat Them

NYC Access Control Installation: Complete Step-by-Step Process Guide

Innovative Spas Announces Exhibit at The Homeowners Expo This July 2026